Abstract
This analysis describes the frequency of markers of evidence-based prescribing of
buprenorphine-containing medications for the treatment of opioid use disorder (OUD) during and surrounding pregnancy in rural and non-rural settings among commercially insured people ages 15-44.
buprenorphine-containing medications for the treatment of opioid use disorder (OUD) during and surrounding pregnancy in rural and non-rural settings among commercially insured people ages 15-44.
| Original language | American English |
|---|---|
| Type | Policy Brief |
| State | Published - Jan 2025 |
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS